Chronic Diseases and Inflammation

The role of alternative splicing in lung disease

The role of alternative splicing in lung disease

A continuing study on the molecular mechanisms underpinning pro and anti-inflammatory pathways in the lung, in particular, the role of alternative splicing in chronic inflammatory lung disease. New therapeutic approaches to treat severe asthma using antisense oligonucleotides are being explored.

To get involved or for more information, contact the Research Leader.

The role of alternative splicing in lung disease was last modified: May 12th, 2016 by Sarah Cermak

Research Leaders

Dr Svetlana Baltic

BSc (Hons), MSc, PhD

Senior Research Fellow

svetlana.baltic@resphealth.uwa.edu.au
LinkedIn

Dr Svetlana Baltic was last modified: December 20th, 2016 by Sarah Cermak

Prof Philip Thompson

MBBS, FRACP,FCCP, MRACMA

Head of Molecular Genetics Unit

phil.thompson@resphealth.uwa.edu.au

Prof Philip Thompson was last modified: December 20th, 2016 by Sarah Cermak

Dr Lucy Barrett

PhD

Research Assistant

lucy.barrett@uwa.edu.au
LinkedIn

Dr Lucy Barrett was last modified: June 12th, 2017 by Sarah Cermak

The role of alternative splicing in lung disease was last modified: May 12th, 2016 by Sarah Cermak